nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—Alfuzosin—CYP3A4—bone cancer	0.0117	0.534	CrCbGaD
Doxazosin—Donepezil—CYP3A4—bone cancer	0.0103	0.466	CrCbGaD
Doxazosin—Muscular weakness—Doxorubicin—bone cancer	0.00155	0.00174	CcSEcCtD
Doxazosin—Neutropenia—Epirubicin—bone cancer	0.00153	0.00173	CcSEcCtD
Doxazosin—Dysuria—Epirubicin—bone cancer	0.00153	0.00173	CcSEcCtD
Doxazosin—Abdominal distension—Doxorubicin—bone cancer	0.00153	0.00172	CcSEcCtD
Doxazosin—Upper respiratory tract infection—Epirubicin—bone cancer	0.00152	0.00172	CcSEcCtD
Doxazosin—Conjunctivitis—Methotrexate—bone cancer	0.00152	0.00171	CcSEcCtD
Doxazosin—Pollakiuria—Epirubicin—bone cancer	0.00151	0.00171	CcSEcCtD
Doxazosin—Sweating—Methotrexate—bone cancer	0.0015	0.00169	CcSEcCtD
Doxazosin—Photosensitivity reaction—Epirubicin—bone cancer	0.00149	0.00168	CcSEcCtD
Doxazosin—Feeling abnormal—Cisplatin—bone cancer	0.00149	0.00168	CcSEcCtD
Doxazosin—Weight increased—Epirubicin—bone cancer	0.00149	0.00168	CcSEcCtD
Doxazosin—Haematuria—Methotrexate—bone cancer	0.00149	0.00168	CcSEcCtD
Doxazosin—Weight decreased—Epirubicin—bone cancer	0.00148	0.00167	CcSEcCtD
Doxazosin—Hyperglycaemia—Epirubicin—bone cancer	0.00148	0.00167	CcSEcCtD
Doxazosin—Angina pectoris—Doxorubicin—bone cancer	0.00148	0.00166	CcSEcCtD
Doxazosin—Epistaxis—Methotrexate—bone cancer	0.00147	0.00166	CcSEcCtD
Doxazosin—Pneumonia—Epirubicin—bone cancer	0.00147	0.00166	CcSEcCtD
Doxazosin—Drowsiness—Epirubicin—bone cancer	0.00146	0.00165	CcSEcCtD
Doxazosin—Bronchitis—Doxorubicin—bone cancer	0.00146	0.00164	CcSEcCtD
Doxazosin—Body temperature increased—Cisplatin—bone cancer	0.00143	0.00162	CcSEcCtD
Doxazosin—Jaundice—Epirubicin—bone cancer	0.00142	0.0016	CcSEcCtD
Doxazosin—Conjunctivitis—Epirubicin—bone cancer	0.00142	0.0016	CcSEcCtD
Doxazosin—Urinary tract infection—Epirubicin—bone cancer	0.00142	0.0016	CcSEcCtD
Doxazosin—Dysuria—Doxorubicin—bone cancer	0.00142	0.0016	CcSEcCtD
Doxazosin—Neutropenia—Doxorubicin—bone cancer	0.00142	0.0016	CcSEcCtD
Doxazosin—Upper respiratory tract infection—Doxorubicin—bone cancer	0.00141	0.00159	CcSEcCtD
Doxazosin—Hepatitis—Methotrexate—bone cancer	0.0014	0.00158	CcSEcCtD
Doxazosin—Sweating—Epirubicin—bone cancer	0.0014	0.00158	CcSEcCtD
Doxazosin—Pollakiuria—Doxorubicin—bone cancer	0.0014	0.00158	CcSEcCtD
Doxazosin—Haematuria—Epirubicin—bone cancer	0.00139	0.00157	CcSEcCtD
Doxazosin—Pharyngitis—Methotrexate—bone cancer	0.00139	0.00157	CcSEcCtD
Doxazosin—Photosensitivity reaction—Doxorubicin—bone cancer	0.00138	0.00156	CcSEcCtD
Doxazosin—Weight increased—Doxorubicin—bone cancer	0.00138	0.00155	CcSEcCtD
Doxazosin—Epistaxis—Epirubicin—bone cancer	0.00138	0.00155	CcSEcCtD
Doxazosin—Weight decreased—Doxorubicin—bone cancer	0.00137	0.00155	CcSEcCtD
Doxazosin—Sinusitis—Epirubicin—bone cancer	0.00137	0.00154	CcSEcCtD
Doxazosin—Hyperglycaemia—Doxorubicin—bone cancer	0.00137	0.00154	CcSEcCtD
Doxazosin—Pneumonia—Doxorubicin—bone cancer	0.00136	0.00153	CcSEcCtD
Doxazosin—Drowsiness—Doxorubicin—bone cancer	0.00135	0.00152	CcSEcCtD
Doxazosin—Visual impairment—Methotrexate—bone cancer	0.00135	0.00152	CcSEcCtD
Doxazosin—Hypersensitivity—Cisplatin—bone cancer	0.00134	0.00151	CcSEcCtD
Doxazosin—Bradycardia—Epirubicin—bone cancer	0.00133	0.0015	CcSEcCtD
Doxazosin—Jaundice—Doxorubicin—bone cancer	0.00132	0.00148	CcSEcCtD
Doxazosin—Rhinitis—Epirubicin—bone cancer	0.00131	0.00148	CcSEcCtD
Doxazosin—Urinary tract infection—Doxorubicin—bone cancer	0.00131	0.00148	CcSEcCtD
Doxazosin—Conjunctivitis—Doxorubicin—bone cancer	0.00131	0.00148	CcSEcCtD
Doxazosin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00131	0.0144	CbGpPWpGaD
Doxazosin—Hepatitis—Epirubicin—bone cancer	0.00131	0.00148	CcSEcCtD
Doxazosin—Eye disorder—Methotrexate—bone cancer	0.00131	0.00148	CcSEcCtD
Doxazosin—Tinnitus—Methotrexate—bone cancer	0.00131	0.00147	CcSEcCtD
Doxazosin—Hypoaesthesia—Epirubicin—bone cancer	0.0013	0.00147	CcSEcCtD
Doxazosin—Asthenia—Cisplatin—bone cancer	0.0013	0.00147	CcSEcCtD
Doxazosin—Pharyngitis—Epirubicin—bone cancer	0.0013	0.00147	CcSEcCtD
Doxazosin—Sweating—Doxorubicin—bone cancer	0.00129	0.00146	CcSEcCtD
Doxazosin—Haematuria—Doxorubicin—bone cancer	0.00129	0.00145	CcSEcCtD
Doxazosin—Epistaxis—Doxorubicin—bone cancer	0.00127	0.00144	CcSEcCtD
Doxazosin—Sinusitis—Doxorubicin—bone cancer	0.00127	0.00143	CcSEcCtD
Doxazosin—Visual impairment—Epirubicin—bone cancer	0.00126	0.00142	CcSEcCtD
Doxazosin—ADRA1D—GPCRs, Other—GRM1—bone cancer	0.00126	0.0139	CbGpPWpGaD
Doxazosin—Chills—Methotrexate—bone cancer	0.00126	0.00142	CcSEcCtD
Doxazosin—Diarrhoea—Cisplatin—bone cancer	0.00124	0.0014	CcSEcCtD
Doxazosin—Alopecia—Methotrexate—bone cancer	0.00124	0.0014	CcSEcCtD
Doxazosin—Bradycardia—Doxorubicin—bone cancer	0.00123	0.00139	CcSEcCtD
Doxazosin—Mental disorder—Methotrexate—bone cancer	0.00123	0.00138	CcSEcCtD
Doxazosin—Eye disorder—Epirubicin—bone cancer	0.00122	0.00138	CcSEcCtD
Doxazosin—Tinnitus—Epirubicin—bone cancer	0.00122	0.00138	CcSEcCtD
Doxazosin—Malnutrition—Methotrexate—bone cancer	0.00122	0.00137	CcSEcCtD
Doxazosin—Flushing—Epirubicin—bone cancer	0.00122	0.00137	CcSEcCtD
Doxazosin—Rhinitis—Doxorubicin—bone cancer	0.00122	0.00137	CcSEcCtD
Doxazosin—Hepatitis—Doxorubicin—bone cancer	0.00121	0.00137	CcSEcCtD
Doxazosin—Hypoaesthesia—Doxorubicin—bone cancer	0.00121	0.00136	CcSEcCtD
Doxazosin—Pharyngitis—Doxorubicin—bone cancer	0.0012	0.00136	CcSEcCtD
Doxazosin—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.0012	0.0132	CbGpPWpGaD
Doxazosin—Dysgeusia—Methotrexate—bone cancer	0.00119	0.00135	CcSEcCtD
Doxazosin—Back pain—Methotrexate—bone cancer	0.00118	0.00133	CcSEcCtD
Doxazosin—Chills—Epirubicin—bone cancer	0.00118	0.00133	CcSEcCtD
Doxazosin—Arrhythmia—Epirubicin—bone cancer	0.00117	0.00132	CcSEcCtD
Doxazosin—Visual impairment—Doxorubicin—bone cancer	0.00117	0.00132	CcSEcCtD
Doxazosin—Alopecia—Epirubicin—bone cancer	0.00116	0.00131	CcSEcCtD
Doxazosin—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.00116	0.0127	CbGpPWpGaD
Doxazosin—Vomiting—Cisplatin—bone cancer	0.00115	0.0013	CcSEcCtD
Doxazosin—Vision blurred—Methotrexate—bone cancer	0.00115	0.0013	CcSEcCtD
Doxazosin—Mental disorder—Epirubicin—bone cancer	0.00115	0.00129	CcSEcCtD
Doxazosin—Rash—Cisplatin—bone cancer	0.00114	0.00129	CcSEcCtD
Doxazosin—Dermatitis—Cisplatin—bone cancer	0.00114	0.00129	CcSEcCtD
Doxazosin—Malnutrition—Epirubicin—bone cancer	0.00114	0.00129	CcSEcCtD
Doxazosin—Eye disorder—Doxorubicin—bone cancer	0.00113	0.00128	CcSEcCtD
Doxazosin—Ill-defined disorder—Methotrexate—bone cancer	0.00113	0.00128	CcSEcCtD
Doxazosin—Tinnitus—Doxorubicin—bone cancer	0.00113	0.00127	CcSEcCtD
Doxazosin—Flushing—Doxorubicin—bone cancer	0.00113	0.00127	CcSEcCtD
Doxazosin—Flatulence—Epirubicin—bone cancer	0.00112	0.00127	CcSEcCtD
Doxazosin—Tension—Epirubicin—bone cancer	0.00112	0.00126	CcSEcCtD
Doxazosin—Dysgeusia—Epirubicin—bone cancer	0.00112	0.00126	CcSEcCtD
Doxazosin—Nervousness—Epirubicin—bone cancer	0.00111	0.00125	CcSEcCtD
Doxazosin—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.0011	0.0121	CbGpPWpGaD
Doxazosin—Back pain—Epirubicin—bone cancer	0.0011	0.00124	CcSEcCtD
Doxazosin—Malaise—Methotrexate—bone cancer	0.0011	0.00124	CcSEcCtD
Doxazosin—Muscle spasms—Epirubicin—bone cancer	0.0011	0.00124	CcSEcCtD
Doxazosin—Vertigo—Methotrexate—bone cancer	0.0011	0.00123	CcSEcCtD
Doxazosin—Leukopenia—Methotrexate—bone cancer	0.00109	0.00123	CcSEcCtD
Doxazosin—Chills—Doxorubicin—bone cancer	0.00109	0.00123	CcSEcCtD
Doxazosin—Arrhythmia—Doxorubicin—bone cancer	0.00108	0.00122	CcSEcCtD
Doxazosin—Nausea—Cisplatin—bone cancer	0.00108	0.00121	CcSEcCtD
Doxazosin—Vision blurred—Epirubicin—bone cancer	0.00108	0.00121	CcSEcCtD
Doxazosin—Alopecia—Doxorubicin—bone cancer	0.00107	0.00121	CcSEcCtD
Doxazosin—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.00107	0.0118	CbGpPWpGaD
Doxazosin—Cough—Methotrexate—bone cancer	0.00106	0.0012	CcSEcCtD
Doxazosin—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.00106	0.0117	CbGpPWpGaD
Doxazosin—Mental disorder—Doxorubicin—bone cancer	0.00106	0.0012	CcSEcCtD
Doxazosin—Ill-defined disorder—Epirubicin—bone cancer	0.00106	0.00119	CcSEcCtD
Doxazosin—Convulsion—Methotrexate—bone cancer	0.00106	0.00119	CcSEcCtD
Doxazosin—Malnutrition—Doxorubicin—bone cancer	0.00106	0.00119	CcSEcCtD
Doxazosin—Agitation—Epirubicin—bone cancer	0.00105	0.00118	CcSEcCtD
Doxazosin—Flatulence—Doxorubicin—bone cancer	0.00104	0.00117	CcSEcCtD
Doxazosin—Chest pain—Methotrexate—bone cancer	0.00104	0.00117	CcSEcCtD
Doxazosin—Myalgia—Methotrexate—bone cancer	0.00104	0.00117	CcSEcCtD
Doxazosin—Arthralgia—Methotrexate—bone cancer	0.00104	0.00117	CcSEcCtD
Doxazosin—Tension—Doxorubicin—bone cancer	0.00104	0.00117	CcSEcCtD
Doxazosin—Dysgeusia—Doxorubicin—bone cancer	0.00103	0.00117	CcSEcCtD
Doxazosin—Malaise—Epirubicin—bone cancer	0.00103	0.00116	CcSEcCtD
Doxazosin—Discomfort—Methotrexate—bone cancer	0.00103	0.00116	CcSEcCtD
Doxazosin—Nervousness—Doxorubicin—bone cancer	0.00103	0.00116	CcSEcCtD
Doxazosin—Vertigo—Epirubicin—bone cancer	0.00102	0.00116	CcSEcCtD
Doxazosin—Syncope—Epirubicin—bone cancer	0.00102	0.00115	CcSEcCtD
Doxazosin—Leukopenia—Epirubicin—bone cancer	0.00102	0.00115	CcSEcCtD
Doxazosin—Back pain—Doxorubicin—bone cancer	0.00102	0.00115	CcSEcCtD
Doxazosin—Muscle spasms—Doxorubicin—bone cancer	0.00101	0.00114	CcSEcCtD
Doxazosin—Palpitations—Epirubicin—bone cancer	0.00101	0.00114	CcSEcCtD
Doxazosin—Confusional state—Methotrexate—bone cancer	0.001	0.00113	CcSEcCtD
Doxazosin—Loss of consciousness—Epirubicin—bone cancer	0.001	0.00113	CcSEcCtD
Doxazosin—Cough—Epirubicin—bone cancer	0.000996	0.00112	CcSEcCtD
Doxazosin—Vision blurred—Doxorubicin—bone cancer	0.000995	0.00112	CcSEcCtD
Doxazosin—Convulsion—Epirubicin—bone cancer	0.000988	0.00111	CcSEcCtD
Doxazosin—Infection—Methotrexate—bone cancer	0.000988	0.00111	CcSEcCtD
Doxazosin—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000985	0.0108	CbGpPWpGaD
Doxazosin—Hypertension—Epirubicin—bone cancer	0.000985	0.00111	CcSEcCtD
Doxazosin—ADRA1D—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.00098	0.0108	CbGpPWpGaD
Doxazosin—Ill-defined disorder—Doxorubicin—bone cancer	0.000979	0.0011	CcSEcCtD
Doxazosin—Thrombocytopenia—Methotrexate—bone cancer	0.000974	0.0011	CcSEcCtD
Doxazosin—Myalgia—Epirubicin—bone cancer	0.000971	0.00109	CcSEcCtD
Doxazosin—Chest pain—Epirubicin—bone cancer	0.000971	0.00109	CcSEcCtD
Doxazosin—Arthralgia—Epirubicin—bone cancer	0.000971	0.00109	CcSEcCtD
Doxazosin—Agitation—Doxorubicin—bone cancer	0.00097	0.00109	CcSEcCtD
Doxazosin—Anxiety—Epirubicin—bone cancer	0.000968	0.00109	CcSEcCtD
Doxazosin—Skin disorder—Methotrexate—bone cancer	0.000966	0.00109	CcSEcCtD
Doxazosin—Hyperhidrosis—Methotrexate—bone cancer	0.000962	0.00108	CcSEcCtD
Doxazosin—Discomfort—Epirubicin—bone cancer	0.00096	0.00108	CcSEcCtD
Doxazosin—Malaise—Doxorubicin—bone cancer	0.000952	0.00107	CcSEcCtD
Doxazosin—Dry mouth—Epirubicin—bone cancer	0.00095	0.00107	CcSEcCtD
Doxazosin—Vertigo—Doxorubicin—bone cancer	0.000948	0.00107	CcSEcCtD
Doxazosin—Anorexia—Methotrexate—bone cancer	0.000948	0.00107	CcSEcCtD
Doxazosin—Syncope—Doxorubicin—bone cancer	0.000947	0.00107	CcSEcCtD
Doxazosin—Leukopenia—Doxorubicin—bone cancer	0.000945	0.00107	CcSEcCtD
Doxazosin—Confusional state—Epirubicin—bone cancer	0.000939	0.00106	CcSEcCtD
Doxazosin—Palpitations—Doxorubicin—bone cancer	0.000933	0.00105	CcSEcCtD
Doxazosin—Oedema—Epirubicin—bone cancer	0.000931	0.00105	CcSEcCtD
Doxazosin—Hypotension—Methotrexate—bone cancer	0.00093	0.00105	CcSEcCtD
Doxazosin—Loss of consciousness—Doxorubicin—bone cancer	0.000928	0.00105	CcSEcCtD
Doxazosin—Infection—Epirubicin—bone cancer	0.000925	0.00104	CcSEcCtD
Doxazosin—Cough—Doxorubicin—bone cancer	0.000921	0.00104	CcSEcCtD
Doxazosin—Shock—Epirubicin—bone cancer	0.000916	0.00103	CcSEcCtD
Doxazosin—Convulsion—Doxorubicin—bone cancer	0.000915	0.00103	CcSEcCtD
Doxazosin—Thrombocytopenia—Epirubicin—bone cancer	0.000912	0.00103	CcSEcCtD
Doxazosin—Hypertension—Doxorubicin—bone cancer	0.000911	0.00103	CcSEcCtD
Doxazosin—Tachycardia—Epirubicin—bone cancer	0.000909	0.00102	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000906	0.00102	CcSEcCtD
Doxazosin—Skin disorder—Epirubicin—bone cancer	0.000904	0.00102	CcSEcCtD
Doxazosin—Hyperhidrosis—Epirubicin—bone cancer	0.0009	0.00101	CcSEcCtD
Doxazosin—Insomnia—Methotrexate—bone cancer	0.0009	0.00101	CcSEcCtD
Doxazosin—Arthralgia—Doxorubicin—bone cancer	0.000899	0.00101	CcSEcCtD
Doxazosin—Myalgia—Doxorubicin—bone cancer	0.000899	0.00101	CcSEcCtD
Doxazosin—Chest pain—Doxorubicin—bone cancer	0.000899	0.00101	CcSEcCtD
Doxazosin—Anxiety—Doxorubicin—bone cancer	0.000896	0.00101	CcSEcCtD
Doxazosin—ADRA1B—LPA receptor mediated events—GNA11—bone cancer	0.000894	0.00982	CbGpPWpGaD
Doxazosin—Paraesthesia—Methotrexate—bone cancer	0.000893	0.00101	CcSEcCtD
Doxazosin—ADRA1D—GPCRs, Other—SMO—bone cancer	0.000888	0.00976	CbGpPWpGaD
Doxazosin—Discomfort—Doxorubicin—bone cancer	0.000888	0.001	CcSEcCtD
Doxazosin—Anorexia—Epirubicin—bone cancer	0.000888	0.001	CcSEcCtD
Doxazosin—Dyspnoea—Methotrexate—bone cancer	0.000887	0.001	CcSEcCtD
Doxazosin—Somnolence—Methotrexate—bone cancer	0.000884	0.000997	CcSEcCtD
Doxazosin—Dry mouth—Doxorubicin—bone cancer	0.000879	0.000991	CcSEcCtD
Doxazosin—Dyspepsia—Methotrexate—bone cancer	0.000876	0.000987	CcSEcCtD
Doxazosin—Hypotension—Epirubicin—bone cancer	0.00087	0.000981	CcSEcCtD
Doxazosin—Confusional state—Doxorubicin—bone cancer	0.000869	0.000979	CcSEcCtD
Doxazosin—Decreased appetite—Methotrexate—bone cancer	0.000865	0.000975	CcSEcCtD
Doxazosin—Oedema—Doxorubicin—bone cancer	0.000862	0.000971	CcSEcCtD
Doxazosin—Fatigue—Methotrexate—bone cancer	0.000858	0.000967	CcSEcCtD
Doxazosin—Infection—Doxorubicin—bone cancer	0.000856	0.000965	CcSEcCtD
Doxazosin—Pain—Methotrexate—bone cancer	0.000851	0.000959	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000848	0.000956	CcSEcCtD
Doxazosin—Shock—Doxorubicin—bone cancer	0.000848	0.000956	CcSEcCtD
Doxazosin—Thrombocytopenia—Doxorubicin—bone cancer	0.000844	0.000951	CcSEcCtD
Doxazosin—Insomnia—Epirubicin—bone cancer	0.000842	0.000949	CcSEcCtD
Doxazosin—Tachycardia—Doxorubicin—bone cancer	0.000841	0.000948	CcSEcCtD
Doxazosin—Skin disorder—Doxorubicin—bone cancer	0.000837	0.000943	CcSEcCtD
Doxazosin—Paraesthesia—Epirubicin—bone cancer	0.000836	0.000943	CcSEcCtD
Doxazosin—Hyperhidrosis—Doxorubicin—bone cancer	0.000833	0.000939	CcSEcCtD
Doxazosin—Dyspnoea—Epirubicin—bone cancer	0.00083	0.000936	CcSEcCtD
Doxazosin—Somnolence—Epirubicin—bone cancer	0.000828	0.000933	CcSEcCtD
Doxazosin—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000825	0.00907	CbGpPWpGaD
Doxazosin—Anorexia—Doxorubicin—bone cancer	0.000821	0.000926	CcSEcCtD
Doxazosin—Feeling abnormal—Methotrexate—bone cancer	0.00082	0.000924	CcSEcCtD
Doxazosin—Dyspepsia—Epirubicin—bone cancer	0.00082	0.000924	CcSEcCtD
Doxazosin—Gastrointestinal pain—Methotrexate—bone cancer	0.000814	0.000917	CcSEcCtD
Doxazosin—ADRA1B—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.000813	0.00894	CbGpPWpGaD
Doxazosin—Decreased appetite—Epirubicin—bone cancer	0.000809	0.000912	CcSEcCtD
Doxazosin—Hypotension—Doxorubicin—bone cancer	0.000805	0.000908	CcSEcCtD
Doxazosin—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000805	0.00885	CbGpPWpGaD
Doxazosin—Fatigue—Epirubicin—bone cancer	0.000803	0.000905	CcSEcCtD
Doxazosin—Pain—Epirubicin—bone cancer	0.000796	0.000898	CcSEcCtD
Doxazosin—Constipation—Epirubicin—bone cancer	0.000796	0.000898	CcSEcCtD
Doxazosin—KCNH7—Circadian rythm related genes—CDK4—bone cancer	0.000795	0.00874	CbGpPWpGaD
Doxazosin—Urticaria—Methotrexate—bone cancer	0.00079	0.000891	CcSEcCtD
Doxazosin—Body temperature increased—Methotrexate—bone cancer	0.000787	0.000887	CcSEcCtD
Doxazosin—Abdominal pain—Methotrexate—bone cancer	0.000787	0.000887	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000785	0.000885	CcSEcCtD
Doxazosin—Insomnia—Doxorubicin—bone cancer	0.000779	0.000878	CcSEcCtD
Doxazosin—Paraesthesia—Doxorubicin—bone cancer	0.000774	0.000872	CcSEcCtD
Doxazosin—Dyspnoea—Doxorubicin—bone cancer	0.000768	0.000866	CcSEcCtD
Doxazosin—Feeling abnormal—Epirubicin—bone cancer	0.000767	0.000865	CcSEcCtD
Doxazosin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000767	0.00843	CbGpPWpGaD
Doxazosin—Somnolence—Doxorubicin—bone cancer	0.000766	0.000863	CcSEcCtD
Doxazosin—Gastrointestinal pain—Epirubicin—bone cancer	0.000761	0.000858	CcSEcCtD
Doxazosin—Dyspepsia—Doxorubicin—bone cancer	0.000758	0.000855	CcSEcCtD
Doxazosin—Decreased appetite—Doxorubicin—bone cancer	0.000749	0.000844	CcSEcCtD
Doxazosin—Fatigue—Doxorubicin—bone cancer	0.000743	0.000837	CcSEcCtD
Doxazosin—Urticaria—Epirubicin—bone cancer	0.00074	0.000834	CcSEcCtD
Doxazosin—Pain—Doxorubicin—bone cancer	0.000737	0.000831	CcSEcCtD
Doxazosin—Constipation—Doxorubicin—bone cancer	0.000737	0.000831	CcSEcCtD
Doxazosin—Abdominal pain—Epirubicin—bone cancer	0.000736	0.00083	CcSEcCtD
Doxazosin—Body temperature increased—Epirubicin—bone cancer	0.000736	0.00083	CcSEcCtD
Doxazosin—Hypersensitivity—Methotrexate—bone cancer	0.000733	0.000826	CcSEcCtD
Doxazosin—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.000723	0.00794	CbGpPWpGaD
Doxazosin—Asthenia—Methotrexate—bone cancer	0.000714	0.000805	CcSEcCtD
Doxazosin—Feeling abnormal—Doxorubicin—bone cancer	0.00071	0.0008	CcSEcCtD
Doxazosin—ADRA1D—G alpha (q) signalling events—GRM1—bone cancer	0.000709	0.00779	CbGpPWpGaD
Doxazosin—Gastrointestinal pain—Doxorubicin—bone cancer	0.000704	0.000794	CcSEcCtD
Doxazosin—Pruritus—Methotrexate—bone cancer	0.000704	0.000794	CcSEcCtD
Doxazosin—Hypersensitivity—Epirubicin—bone cancer	0.000686	0.000773	CcSEcCtD
Doxazosin—Urticaria—Doxorubicin—bone cancer	0.000684	0.000772	CcSEcCtD
Doxazosin—Abdominal pain—Doxorubicin—bone cancer	0.000681	0.000768	CcSEcCtD
Doxazosin—Body temperature increased—Doxorubicin—bone cancer	0.000681	0.000768	CcSEcCtD
Doxazosin—Diarrhoea—Methotrexate—bone cancer	0.000681	0.000767	CcSEcCtD
Doxazosin—Asthenia—Epirubicin—bone cancer	0.000668	0.000753	CcSEcCtD
Doxazosin—Pruritus—Epirubicin—bone cancer	0.000659	0.000743	CcSEcCtD
Doxazosin—Dizziness—Methotrexate—bone cancer	0.000658	0.000742	CcSEcCtD
Doxazosin—Diarrhoea—Epirubicin—bone cancer	0.000637	0.000718	CcSEcCtD
Doxazosin—ADRA2A—Regulation of insulin secretion—GNA11—bone cancer	0.000636	0.00699	CbGpPWpGaD
Doxazosin—Hypersensitivity—Doxorubicin—bone cancer	0.000635	0.000716	CcSEcCtD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.000634	0.00697	CbGpPWpGaD
Doxazosin—Vomiting—Methotrexate—bone cancer	0.000633	0.000713	CcSEcCtD
Doxazosin—Rash—Methotrexate—bone cancer	0.000627	0.000707	CcSEcCtD
Doxazosin—Dermatitis—Methotrexate—bone cancer	0.000627	0.000707	CcSEcCtD
Doxazosin—Headache—Methotrexate—bone cancer	0.000623	0.000703	CcSEcCtD
Doxazosin—Asthenia—Doxorubicin—bone cancer	0.000618	0.000697	CcSEcCtD
Doxazosin—Dizziness—Epirubicin—bone cancer	0.000616	0.000694	CcSEcCtD
Doxazosin—Pruritus—Doxorubicin—bone cancer	0.00061	0.000687	CcSEcCtD
Doxazosin—KCNH6—Neuronal System—BRAF—bone cancer	0.000607	0.00667	CbGpPWpGaD
Doxazosin—Vomiting—Epirubicin—bone cancer	0.000592	0.000667	CcSEcCtD
Doxazosin—Nausea—Methotrexate—bone cancer	0.000591	0.000666	CcSEcCtD
Doxazosin—Diarrhoea—Doxorubicin—bone cancer	0.000589	0.000665	CcSEcCtD
Doxazosin—ADRA1B—G alpha (q) signalling events—GRM1—bone cancer	0.000588	0.00646	CbGpPWpGaD
Doxazosin—Rash—Epirubicin—bone cancer	0.000587	0.000662	CcSEcCtD
Doxazosin—Dermatitis—Epirubicin—bone cancer	0.000587	0.000661	CcSEcCtD
Doxazosin—Headache—Epirubicin—bone cancer	0.000583	0.000658	CcSEcCtD
Doxazosin—Dizziness—Doxorubicin—bone cancer	0.00057	0.000642	CcSEcCtD
Doxazosin—Nausea—Epirubicin—bone cancer	0.000553	0.000623	CcSEcCtD
Doxazosin—Vomiting—Doxorubicin—bone cancer	0.000548	0.000618	CcSEcCtD
Doxazosin—ADRA1D—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000548	0.00602	CbGpPWpGaD
Doxazosin—Rash—Doxorubicin—bone cancer	0.000543	0.000612	CcSEcCtD
Doxazosin—Dermatitis—Doxorubicin—bone cancer	0.000543	0.000612	CcSEcCtD
Doxazosin—KCNH7—Neuronal System—BRAF—bone cancer	0.000541	0.00595	CbGpPWpGaD
Doxazosin—Headache—Doxorubicin—bone cancer	0.00054	0.000608	CcSEcCtD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.000526	0.00578	CbGpPWpGaD
Doxazosin—ADRA1A—G alpha (q) signalling events—GRM1—bone cancer	0.000522	0.00574	CbGpPWpGaD
Doxazosin—KCNH7—Circadian rythm related genes—JUN—bone cancer	0.000512	0.00563	CbGpPWpGaD
Doxazosin—Nausea—Doxorubicin—bone cancer	0.000512	0.000577	CcSEcCtD
Doxazosin—KCNH6—Neuronal System—MDM2—bone cancer	0.000509	0.00559	CbGpPWpGaD
Doxazosin—ADRA2A—Integration of energy metabolism—GNA11—bone cancer	0.0005	0.0055	CbGpPWpGaD
Doxazosin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000499	0.00548	CbGpPWpGaD
Doxazosin—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000492	0.00541	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.000467	0.00514	CbGpPWpGaD
Doxazosin—ADRA2A—G alpha (i) signalling events—GRM4—bone cancer	0.000466	0.00513	CbGpPWpGaD
Doxazosin—ADRA2A—G alpha (i) signalling events—RGS1—bone cancer	0.000466	0.00513	CbGpPWpGaD
Doxazosin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000459	0.00504	CbGpPWpGaD
Doxazosin—ADRA1D—G alpha (q) signalling events—GNA11—bone cancer	0.000457	0.00502	CbGpPWpGaD
Doxazosin—ADRA1B—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000454	0.005	CbGpPWpGaD
Doxazosin—KCNH7—Neuronal System—MDM2—bone cancer	0.000453	0.00498	CbGpPWpGaD
Doxazosin—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000453	0.00498	CbGpPWpGaD
Doxazosin—ADRA1B—LPA receptor mediated events—MMP2—bone cancer	0.000419	0.00461	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—GRM4—bone cancer	0.000412	0.00453	CbGpPWpGaD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000408	0.00449	CbGpPWpGaD
Doxazosin—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000404	0.00444	CbGpPWpGaD
Doxazosin—ADRA1A—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000404	0.00444	CbGpPWpGaD
Doxazosin—ADRA1B—G alpha (q) signalling events—GNA11—bone cancer	0.000379	0.00417	CbGpPWpGaD
Doxazosin—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000372	0.00409	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—GRM1—bone cancer	0.000357	0.00393	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—GRM4—bone cancer	0.000342	0.00376	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000339	0.00373	CbGpPWpGaD
Doxazosin—KCNH7—Circadian rythm related genes—TP53—bone cancer	0.000338	0.00372	CbGpPWpGaD
Doxazosin—ADRA1A—G alpha (q) signalling events—GNA11—bone cancer	0.000337	0.0037	CbGpPWpGaD
Doxazosin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000334	0.00367	CbGpPWpGaD
Doxazosin—ADRA1B—LPA receptor mediated events—JUN—bone cancer	0.000324	0.00356	CbGpPWpGaD
Doxazosin—ADRA1B—LPA receptor mediated events—MMP9—bone cancer	0.000315	0.00346	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—GRM4—bone cancer	0.000304	0.00334	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000301	0.00331	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000299	0.00329	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—GRM1—bone cancer	0.000297	0.00326	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—GRM4—bone cancer	0.000282	0.0031	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000274	0.00301	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000273	0.00301	CbGpPWpGaD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—JUN—bone cancer	0.000266	0.00292	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—GRM1—bone cancer	0.000263	0.0029	CbGpPWpGaD
Doxazosin—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000256	0.00281	CbGpPWpGaD
Doxazosin—ADRA1B—LPA receptor mediated events—EGFR—bone cancer	0.000254	0.0028	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—SMO—bone cancer	0.000252	0.00277	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000248	0.00273	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—GRM1—bone cancer	0.000245	0.00269	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—RGS1—bone cancer	0.000233	0.00256	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—GRM4—bone cancer	0.000233	0.00256	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000232	0.00256	CbGpPWpGaD
Doxazosin—KCNH2—Neuronal System—BRAF—bone cancer	0.000229	0.00252	CbGpPWpGaD
Doxazosin—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.000215	0.00236	CbGpPWpGaD
Doxazosin—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	0.000212	0.00233	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000212	0.00233	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—RGS1—bone cancer	0.000212	0.00233	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—GRM4—bone cancer	0.000212	0.00233	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—SMO—bone cancer	0.000209	0.0023	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—GRM1—bone cancer	0.000202	0.00222	CbGpPWpGaD
Doxazosin—ADRA1B—AMPK Signaling—TP53—bone cancer	0.000201	0.00221	CbGpPWpGaD
Doxazosin—CYP2D6—Biological oxidations—CYP3A4—bone cancer	0.000198	0.00217	CbGpPWpGaD
Doxazosin—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	0.000195	0.00214	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—RGS1—bone cancer	0.000193	0.00213	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—GRM4—bone cancer	0.000193	0.00213	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000193	0.00212	CbGpPWpGaD
Doxazosin—KCNH2—Neuronal System—MDM2—bone cancer	0.000192	0.00211	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.00019	0.00209	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—SMO—bone cancer	0.000186	0.00204	CbGpPWpGaD
Doxazosin—CYP2C19—Biological oxidations—GSTP1—bone cancer	0.000184	0.00202	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—GRM1—bone cancer	0.000183	0.00202	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—NDUFA12—bone cancer	0.000182	0.002	CbGpPWpGaD
Doxazosin—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	0.000181	0.00199	CbGpPWpGaD
Doxazosin—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	0.00018	0.00198	CbGpPWpGaD
Doxazosin—ADRA1A—AMPK Signaling—TP53—bone cancer	0.000179	0.00196	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—GRM4—bone cancer	0.000176	0.00193	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—RGS1—bone cancer	0.000176	0.00193	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—SMO—bone cancer	0.000172	0.0019	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—GRM4—bone cancer	0.000172	0.00189	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—RGS1—bone cancer	0.000172	0.00189	CbGpPWpGaD
Doxazosin—CYP2D6—Biological oxidations—GSTP1—bone cancer	0.000169	0.00186	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—GRM1—bone cancer	0.000168	0.00184	CbGpPWpGaD
Doxazosin—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	0.000167	0.00183	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000161	0.00177	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000161	0.00177	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—RGS1—bone cancer	0.00016	0.00175	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—GRM4—bone cancer	0.00016	0.00175	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—GRM4—bone cancer	0.000156	0.00171	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—RGS1—bone cancer	0.000156	0.00171	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—SPARC—bone cancer	0.000154	0.0017	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—GRM1—bone cancer	0.000152	0.00167	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—NT5C3A—bone cancer	0.000151	0.00166	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—GRM1—bone cancer	0.000149	0.00164	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—GRM4—bone cancer	0.000145	0.00159	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—RGS1—bone cancer	0.000145	0.00159	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—GNA11—bone cancer	0.000141	0.00155	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000139	0.00153	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—GRM1—bone cancer	0.000138	0.00152	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—GRM1—bone cancer	0.000135	0.00149	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—GNA11—bone cancer	0.00013	0.00143	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—SMO—bone cancer	0.000129	0.00142	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NDUFA12—bone cancer	0.000129	0.00142	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—IL3—bone cancer	0.000128	0.00141	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NDUFA12—bone cancer	0.000126	0.00138	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—GRM1—bone cancer	0.000126	0.00138	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RGS1—bone cancer	0.000125	0.00137	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—GRM4—bone cancer	0.000125	0.00137	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.00012	0.00131	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NDUFA12—bone cancer	0.000118	0.0013	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—GNA11—bone cancer	0.000118	0.0013	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—IL3—bone cancer	0.000118	0.0013	CbGpPWpGaD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000116	0.00128	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—GRM1—bone cancer	0.000108	0.00119	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—GNA11—bone cancer	0.000108	0.00119	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—SMO—bone cancer	0.000107	0.00118	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL3—bone cancer	0.000107	0.00118	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NT5C3A—bone cancer	0.000107	0.00117	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NT5C3A—bone cancer	0.000104	0.00114	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—GRM4—bone cancer	0.000104	0.00114	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RGS1—bone cancer	0.000104	0.00114	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NT5C3A—bone cancer	9.81e-05	0.00108	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—GNA11—bone cancer	9.81e-05	0.00108	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—IL3—bone cancer	9.79e-05	0.00108	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	9.65e-05	0.00106	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—GNA11—bone cancer	9.59e-05	0.00105	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—SMO—bone cancer	9.53e-05	0.00105	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—GRM4—bone cancer	9.21e-05	0.00101	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RGS1—bone cancer	9.21e-05	0.00101	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—GRM1—bone cancer	8.99e-05	0.000988	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—GNA11—bone cancer	8.91e-05	0.00098	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL3—bone cancer	8.89e-05	0.000977	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	8.86e-05	0.000974	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—SMO—bone cancer	8.85e-05	0.000973	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—GNA11—bone cancer	8.71e-05	0.000958	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—IL3—bone cancer	8.7e-05	0.000956	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	8.57e-05	0.000942	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RGS1—bone cancer	8.56e-05	0.000941	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GRM4—bone cancer	8.56e-05	0.000941	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	8.54e-05	0.000939	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—PLAU—bone cancer	8.39e-05	0.000922	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—GNA11—bone cancer	8.09e-05	0.00089	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—IL3—bone cancer	8.08e-05	0.000888	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—GRM1—bone cancer	7.99e-05	0.000878	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL3—bone cancer	7.9e-05	0.000868	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	7.7e-05	0.000847	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SMO—bone cancer	7.63e-05	0.000839	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GRM1—bone cancer	7.42e-05	0.000816	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL3—bone cancer	7.34e-05	0.000807	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—GNA11—bone cancer	6.98e-05	0.000767	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ENO2—bone cancer	6.6e-05	0.000725	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ATF1—bone cancer	6.49e-05	0.000713	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SMO—bone cancer	6.33e-05	0.000696	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL3—bone cancer	6.33e-05	0.000696	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—DHFR—bone cancer	6.12e-05	0.000673	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	6.06e-05	0.000666	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—GNA11—bone cancer	5.79e-05	0.000637	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GNA11—bone cancer	5.72e-05	0.000629	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SMO—bone cancer	5.63e-05	0.000619	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TGFBR2—bone cancer	5.41e-05	0.000595	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ATF1—bone cancer	5.39e-05	0.000592	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL3—bone cancer	5.25e-05	0.000577	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SMO—bone cancer	5.23e-05	0.000575	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CYP3A4—bone cancer	5.18e-05	0.00057	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—GNA11—bone cancer	5.15e-05	0.000566	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IGF1R—bone cancer	5.09e-05	0.00056	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	5.08e-05	0.000559	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ATF1—bone cancer	4.78e-05	0.000526	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GNA11—bone cancer	4.78e-05	0.000526	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ENO2—bone cancer	4.67e-05	0.000514	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL3—bone cancer	4.67e-05	0.000513	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ENO2—bone cancer	4.56e-05	0.000501	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	4.49e-05	0.000494	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ATF1—bone cancer	4.45e-05	0.000489	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GSTP1—bone cancer	4.43e-05	0.000487	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL3—bone cancer	4.34e-05	0.000477	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—DHFR—bone cancer	4.33e-05	0.000477	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ENO2—bone cancer	4.3e-05	0.000472	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—DHFR—bone cancer	4.23e-05	0.000465	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IGF1R—bone cancer	4.23e-05	0.000465	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GNA11—bone cancer	4.05e-05	0.000445	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	3.99e-05	0.000439	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—DHFR—bone cancer	3.99e-05	0.000438	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GNA11—bone cancer	3.95e-05	0.000435	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IGF1R—bone cancer	3.75e-05	0.000413	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GNA11—bone cancer	3.73e-05	0.00041	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	3.71e-05	0.000408	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—KIT—bone cancer	3.69e-05	0.000406	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP3A4—bone cancer	3.67e-05	0.000404	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.65e-05	0.000402	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP3A4—bone cancer	3.59e-05	0.000394	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IGF1R—bone cancer	3.49e-05	0.000383	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—BRAF—bone cancer	3.47e-05	0.000382	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP3A4—bone cancer	3.38e-05	0.000371	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TP53—bone cancer	3.37e-05	0.000371	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—EGFR—bone cancer	3.36e-05	0.00037	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTP1—bone cancer	3.14e-05	0.000345	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTP1—bone cancer	3.07e-05	0.000337	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KIT—bone cancer	3.07e-05	0.000337	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MDM2—bone cancer	2.91e-05	0.00032	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTP1—bone cancer	2.89e-05	0.000318	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—BRAF—bone cancer	2.88e-05	0.000317	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—EGFR—bone cancer	2.79e-05	0.000307	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KIT—bone cancer	2.72e-05	0.000299	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—BRAF—bone cancer	2.56e-05	0.000281	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KIT—bone cancer	2.53e-05	0.000278	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—JUN—bone cancer	2.53e-05	0.000278	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—EGFR—bone cancer	2.48e-05	0.000273	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MMP9—bone cancer	2.46e-05	0.00027	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MDM2—bone cancer	2.41e-05	0.000265	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—BRAF—bone cancer	2.38e-05	0.000261	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—EGFR—bone cancer	2.3e-05	0.000253	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTGS2—bone cancer	2.3e-05	0.000253	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MDM2—bone cancer	2.14e-05	0.000236	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—JUN—bone cancer	2.1e-05	0.000231	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MMP9—bone cancer	2.04e-05	0.000224	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MDM2—bone cancer	1.99e-05	0.000219	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—EGFR—bone cancer	1.99e-05	0.000219	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—JUN—bone cancer	1.86e-05	0.000205	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MMP9—bone cancer	1.81e-05	0.000199	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—JUN—bone cancer	1.73e-05	0.00019	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP9—bone cancer	1.68e-05	0.000185	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TP53—bone cancer	1.67e-05	0.000183	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EGFR—bone cancer	1.65e-05	0.000181	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTGS2—bone cancer	1.63e-05	0.000179	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTGS2—bone cancer	1.59e-05	0.000175	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTGS2—bone cancer	1.5e-05	0.000165	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EGFR—bone cancer	1.47e-05	0.000161	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TP53—bone cancer	1.39e-05	0.000152	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EGFR—bone cancer	1.36e-05	0.00015	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TP53—bone cancer	1.23e-05	0.000135	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TP53—bone cancer	1.14e-05	0.000126	CbGpPWpGaD
